Global Collaboration Is Key to Progress in Gastroesophageal Cancers
Read up on Oncology Live how international cooperation among specialists is crucial to the advancement of care for gastric cancer patients.
Ramucirumab Shows Promise in Care of Advanced Gastric Cancer
A study published from the Journal of Gastroenterology and Hepatology shows Ramucirumab as a safe and effective treatment of advanced gastric cancer.
Patient Selection for Immunotherapy in Gastric Cancer
Curious about patient selection for immunotherapy in treating gastric cancer? Scientists explain here.
Lumican expression in gastric cancer and its association with biological behavior and prognosis
A new study found an association between lumican expression and invasive potential in gastric cancer and may be an independent prognostic factor.
AKT inhibition is an effective treatment strategy in ARID1A-deficient gastric cancer cells
Researchers look into At-Rich Interactive Domain 1A (ARID1A), which is frequently mutated in gastric cancers with poor prognosis, finding AKT inhibition might... Read More
The role of intestinal bacteria in the development and progression of gastrointestinal tract neoplasms
New research shows gut microbiota may affect chemotherapy efficacy and immunotherapy as well as impact post-surgery complications in gastric cancer patients.
High PROX1 expression in gastric cancer predicts better survival
A recent study investigates PROX1 expression in gastric cancer, which is a transcription factor involved in various organ development. Researchers found high... Read More
ESMO 2017 Press Release: Pembrolizumab: Promising Response Rate in Pretreated Metastatic Gastric Cancer
Breaking news was just released at the European Society for Medical Oncology Congress in Madrid: new data in phase two of the... Read More
A randomised phase II study of continuous versus stop-and-go S-1 plus oxaliplatin following disease stabilisation in first-line chemotherapy in patients with metastatic gastric cancer
A new Oncology Advance study finds benefits to stop-and-go chemotherapy in treating metastatic gastric cancer. Researchers found that continuous treatment boosted progression-free... Read More
A phase III trial comparing oral S-1/cisplatin and intravenous 5-fluorouracil/cisplatin in patients with untreated diffuse gastric cancer
In an international phase 3 trial, researchers find S-1 (a contemporary oral fluoropyrimidine)/ cisplatin and 5-fluorouracil (5-FU)/cisplatin are similar in efficacy and... Read More
